Skip to main content
. 2021 Mar 9;10(2):637–661. doi: 10.1007/s40121-021-00404-y

Table 2.

Suggested schedule for immunisation in adults with asplenia/splenic hypofunction and splenectomy

Vaccination history Month 0 Month 1 Month 2 After month 2
Unvaccinated

Hib/MenACWY

First dose PCV

Seasonal influenzaa

MenB MenACWY

PPV at least 2 months after PCV

Seasonal influenzaa

PPV

Hib/MenACWY/MenB

PCV (at least 1 year after PPV)

Seasonal influenzaa

MenB MenACWY

MenACWY every 5 years

PPV 5 years after PPV

Seasonal influenzaa

MenACWY/MenB vaccination (> 5 years)

Hib/MenACWY

PCV13 (at least 1 year after PPV)

Seasonal influenzaa

MenB MenACWY

MenACWY every 5 years

PPV 5 years after PPV

Seasonal influenzaa

Completed MenACWY/MenC; Hib and PCV vaccination more than 5 years before

Hib/MenACWY

PCV

Seasonal influenzaa

MenB PPV

MenACWY every 5 years

PPV 5 years after PPV

Seasonal influenza∞

Timing: Functional asplenia—as soon as possible. Surgical asplenia (elective)—complete the vaccination schedule 4–6 weeks before surgery; if not possible, complete at least 2 weeks before surgery. Surgical asplenia (emergency)—start the vaccination schedule at least 2 weeks after the operation or as soon as the clinical conditions permit

PCV pneumococcal conjugate vaccine, PPV pneumococcal polysaccharide vaccine, Hib H. influenzae type b vaccine, MenACWY N. menigitidis serotypes A, C, W, Y vaccine, MenC N. meningitidis C vaccine

aOtherwise healthy asplenic patients 2–49 years of age may be vaccinated with live attenuated influenza vaccine, except patients with sickle cell disease, who should receive inactivated influenza vaccine